| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| LINC00339 |
|
long intergenic non-protein coding RNA 339
|
|
|
0.695 |
0.346 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
| AFAP1-AS1 |
|
AFAP1 antisense RNA 1
|
|
|
0.573 |
0.538 |
| CYTOR |
|
cytoskeleton regulator RNA
|
|
|
0.568 |
0.577 |
| ANIB1 |
|
aneurysm, intracranial berry 1
|
|
|
0.608 |
0.500 |
| LINC00261 |
|
long intergenic non-protein coding RNA 261
|
|
|
0.705 |
0.308 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| FEZF1-AS1 |
|
FEZF1 antisense RNA 1
|
|
|
0.644 |
0.615 |
| ZEB1-AS1 |
|
ZEB1 antisense RNA 1
|
|
|
0.636 |
0.423 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| HOXA-AS2 |
|
HOXA cluster antisense RNA 2
|
|
|
0.663 |
0.385 |
| DLX6-AS1 |
|
DLX6 antisense RNA 1
|
|
|
0.628 |
0.423 |
| PWAR4 |
|
Prader Willi/Angelman region RNA 4
|
|
|
0.573 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| HAGLR |
|
HOXD antisense growth-associated long non-coding RNA
|
|
|
0.619 |
0.385 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |